Quotient Sciences Acquires Arcinova

Read the press release here

Evening Chronicle Article

Last month the Evening Chronicle featured an article regarding the formation of ARC Trinova & Arcinova. The article explains that the formation of ARC Trinova, trading as Arcinova, has saved fifty jobs following the decision from Sanofi to close the Covance site in Alnwick. 

Anne-Marie Trevelyan, MP for Berwick-upon-Tweed, said: “It is good news for Alnwick and Northumberland that we will be retaining ground-breaking drug development capabilities in our area.


“I thank the Office for Life Sciences, and the Life Sciences Minister George Freeman, for the assistance and resources they have put in alongside the local taskforce, whose support has been excellent.


“It is also good to hear that a minimum of 50 of the talented workforce will stay on, and that the taskforce remains on hand to offer assistance to staff.


“I will continue to offer all the support I can throughout the transition process, and I have received assurances from the minister that his office remains at the disposal of the taskforce.”


Click here to read the full article.

Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.